Bartlett & Co Wealth Management’s NanoViricides NNVC Stock Holding History

Bartlett & Co Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,036	Closed	-$15.2K	–	860
2020 Q2	$15.2K	Hold	2,036	–	–	﹤0.01%	640
2020 Q1	$11.7K	Hold	2,036	–	–	﹤0.01%	642
2019 Q4	$5.11K	Hold	2,036	–	–	﹤0.01%	761
2019 Q3	$4.17K	Hold	2,036	–	–	﹤0.01%	792
2019 Q2	$9.77K	Hold	2,036	–	–	﹤0.01%	587
2019 Q1	$11K	Hold	2,036	–	–	﹤0.01%	572
2018 Q4	$8.14K	Hold	2,036	–	–	﹤0.01%	594
2018 Q3	$14.7K	Hold	2,036	–	–	﹤0.01%	573
2018 Q2	$17.9K	Hold	2,036	–	–	﹤0.01%	541
2018 Q1	$33.4K	Buy	+2,036	New	+$37.7K	﹤0.01%	473

Other funds holding NNVC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HIS

Harvest Investment Services Oakbrook Terrace, Illinois $647M AUM 89.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bartlett & Co Wealth Management's NNVC Position: Q3 2020 in Review

Bartlett & Co Wealth Management sold out of NanoViricides (NNVC) in Q3 2020, closing a stake of 2,036 shares — an estimated $15.2K sold.

Bartlett & Co Wealth Management first reported a position in NNVC in Q1 2018 and held it in 10 quarters. The position peaked at $33.4K in Q1 2018. 36 funds tracked by Wall St. Rank hold NNVC as of Q3 2020.

Bartlett & Co Wealth Management reported no remaining NanoViricides position as of Q3 2020 after selling out during the quarter.
Bartlett & Co Wealth Management sold 2,036 NanoViricides shares in Q3 2020, an estimated $15.2K.
Bartlett & Co Wealth Management first reported a position in NanoViricides in Q1 2018 and held it in 10 quarters.
Bartlett & Co Wealth Management's NanoViricides position peaked at $33.4K in Q1 2018.
36 funds tracked by Wall St. Rank held NanoViricides as of Q3 2020.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2020, filed 13 Feb 2024.